|
IPO
MCID: INT072
|
Intestinal Pseudo-obstruction malady |
|
Sources: 30NIH Rare Diseases, 17Genetics Home Reference, 44Wikipedia, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: Intestinal pseudo-obstruction is a digestive disorder in which the intestinal walls are unable to contract normally (called hypomotility); the condition resembles a true obstruction, but no actual blockage exists. Signs and symptoms may include abdominal pain; vomiting; diarrhea; constipation; malabsorption of nutrients leading to weight loss and/or failure to thrive; and other symptoms. It may be classified as neuropathic (from lack of nerve function) or myopathic (from lack of muscle function), depending on the source of the abnormality. The condition is sometimes inherited (in an X-linked recessive or autosomal dominant manner) and may be caused by mutations in the FLNA gene; it may also be acquired after certain illnesses. The goal of treatment is to provide relief from symptoms and ensure that nutritional support is adequate.30
MalaCards: Intestinal Pseudo-obstruction, also known as intestinal pseudoobstruction, is related to pulmonary disease and apnea. An important gene associated with Intestinal Pseudo-obstruction is SOX10 (SRY (sex determining region Y)-box 10), and among its related pathways are Bacterial infections in CF airways and G alpha (q) signalling events. The compounds Monoisopropylphosphorylserine and sodium nitroprusside have been mentioned in the context of this disorder. Affiliated tissues include smooth muscle, and related mouse phenotypes are liver/biliary system and endocrine/exocrine gland. Genetics Home Reference: Intestinal pseudo-obstruction is a condition characterized by impairment of the muscle contractions that move food through the digestive tract. The condition may arise from abnormalities of the gastrointestinal muscles themselves (myogenic) or from problems with the nerves that control the muscle contractions (neurogenic).17 Wikipedia: Intestinal Pseudo-obstruction is a clinical syndrome caused by severe impairment in the ability of the...44 more... |
|
Sources: 6Disease Ontology, 7diseasecard, 30NIH Rare Diseases, 17Genetics Home Reference, 8DISEASES, 32Novoseek , 43UMLS, 27NCIt, 24MeSH, 40SNOMED-CT See all sources |
Aliases & Descriptions:
|
|
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for intestinal pseudo-obstruction Drug clinical trials:Search ClinicalTrials for intestinal pseudo-obstruction Search NIH Clinical Center for intestinal pseudo-obstruction Search CenterWatch for intestinal pseudo-obstruction |
|
|
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to intestinal pseudo-obstruction:22Smooth muscle
|
|
Sources: 25MGI See all sources |
MGI Mouse Phenotypes related to intestinal pseudo-obstruction:25 (show all 18)
|
|
Sources: 35PubMed See all sources |
Articles related to intestinal pseudo-obstruction:(show all 20)
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 41Thomson Reuters, 38Reactome See all sources |
Pathways related to intestinal pseudo-obstruction according to GeneDecks:
|
|
Sources: 9DrugBank, 32Novoseek , 42Tocris Bioscience, 18HMDB, 34PharmGKB See all sources |
Compounds related to intestinal pseudo-obstruction according to GeneDecks:(show top 50) (show all 69)
|
|
Sources: 12Gene Ontology See all sources |
Cellular components related to intestinal pseudo-obstruction according to GeneDecks:
Biological processes related to intestinal pseudo-obstruction according to GeneDecks:(show all 9)
|
